Chengdu, China

Xiaoguang Bai

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Hitgen, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaoguang Bai. Retrieved from https://idiyas.com/inventor/xiaoguang-bai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Xiaoguang Bai - Innovator in Antibody Drug Conjugates

Introduction

Xiaoguang Bai is a notable inventor based in Chengdu, China. He is currently associated with Hitgen, Inc., where he focuses on innovative solutions in the field of biotechnology. Although he does not have any granted patents to his name, his contributions to the field are significant through his latest patent applications.

Latest Patent Applications

Xiaoguang Bai has recently filed several patent applications that showcase his innovative work. One of his applications is titled "STING Agonist Suitable as Payload of Antibody Drug Conjugate." This application discloses a compound-linker conjugate and a class of compounds that exhibit STING activation activity, along with their applications in the preparation of antibody drug conjugates. The compounds are represented as suitable payloads for these conjugates. Another application is for an "Immunomodulator," which discloses a compound capable of inhibiting interleukin 17A (IL-17A). This application provides details on the compound or its stereoisomer in the preparation of drugs aimed at inhibiting IL-17A.

Conclusion

Xiaoguang Bai is an emerging inventor whose work in antibody drug conjugates and immunomodulators holds promise for advancements in biotechnology. His latest patent applications reflect his commitment to innovation in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…